Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

September 21, 2017

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary pharmaceutical and health care solutions company, today announced that an amendment to its bylaws has been approved by the directors, whereby the quorum for the transaction of business at any meeting of the shareholders shall… [ READ MORE ]

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

September 21, 2017

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will present at the 2017 Disruptive Growth Company Showcase NYC, presented by SeeThruEquity and RHK Capital, on Wednesday, September 27 at the Grand Hyatt in New York City. Chief Executive… [ READ MORE ]

Zomedica Appoints PCG Advisory Group for Investor Relations and Announces Option Grants

August 14, 2017

ANN ARBOR, Mich., Aug. 14, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V: ZOM) (“Zomedica”), a veterinary pharmaceutical and health care solutions company, today announced that it has retained PCG Advisory Group, a leading integrated communications firm, to serve as an advisor for investor relations and social media communications strategies. “We are very pleased to… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Announces Second Quarter 2017 Financial Results

August 10, 2017

ANN ARBOR, Mich., Aug. 10, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed unaudited interim consolidated financial results for the three and six months ended June 30, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under International… [ READ MORE ]

Zomedica Strengthens Executive Leadership Team

July 10, 2017

ANN ARBOR, Mich., July 10, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that Bruk Herbst has joined the company as Chief Commercial Officer. In this new company position, he is responsible for delivering and executing Zomedica’s commercial strategy, as well as leading the company’s… [ READ MORE ]

Zomedica Pharmaceuticals Corp. to Present at The MicroCap Conference 2017 in Toronto

June 20, 2017

ANN ARBOR, Mich., June 20, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will present at The MicroCap Conference, on Tuesday, June 27 at the Sheraton Centre Hotel in Toronto, Canada. Chief Executive Officer Gerald Solensky Jr. will provide an overview of Zomedica’s… [ READ MORE ]

Zomedica Announces 2017 Annual Meeting Results

June 2, 2017

ANN ARBOR, Mich., June 2, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, is pleased to announce that all ordinary and special resolutions were passed at the Annual and Special Meeting of Shareholders, which was held today in Toronto, Ontario, Canada. An aggregate of… [ READ MORE ]

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

May 11, 2017

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today reported condensed unaudited interim consolidated financial results for the three months ended March 31, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under International Financial Reporting… [ READ MORE ]

Zomedica Announces Adoption of Advance Notice Bylaw

April 28, 2017

ANN ARBOR, Mich., April 28, 2017 (GLOBE NEWSWIRE) – Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, announces the adoption of an advance notice bylaw (the “Advance Notice Bylaw”). The Advance Notice Bylaw includes, among other things, a provision that requires advance notice to be given to the… [ READ MORE ]